Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:24 2026-10-02 am EDT
|
5-day change | 1st Jan Change | ||
| 0.3800 AUD | -7.32% |
|
-8.43% | -5.00% |
| Sep. 16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
| Aug. 30 | Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options | MT |
| Market Cap | 58.06M 51.56M 48.22M 43.94M 82.73M 5.59B 83.87M 583M 226M 2.85B 218M 213M 9.14B | P/E 2027 * |
-3x | P/E 2028 * | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.15M 15.24M 14.25M 12.98M 24.44M 1.65B 24.78M 172M 66.72M 841M 64.4M 63M 2.7B | EV / Sales 2027 * |
36.1x | EV / Sales 2028 * | 10.6x |
| Free-Float |
97.02% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATH | Delayed | |
OTC Markets
| PRNAF | Delayed | |
|
Deutsche Boerse AG
| PBN | Delayed | |
|
Börse Stuttgart
| PBN | Delayed |
Last Transcript: Alterity Therapeutics Limited
| 1 day | -7.32% | ||
| 1 week | -8.43% | ||
| Current month | -5.59% | ||
| 1 month | -26.92% | ||
| 3 months | -41.54% | ||
| 6 months | -15.56% | ||
| Current year | -5.00% |
| 1 week | 0.38 |  | 0.44 |
| 1 month | 0.38 | | 0.52 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.78 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.65 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 2021-01-06 |
| Director of Finance/CFO | - | 2024-09-29 | |
| Chief Tech/Sci/R&D Officer | - | 2019-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 2005-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 2011-08-07 |
David Stamler
BRD | Director/Board Member | 65 | 2025-11-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Exercice | Director | 47,620 | 0.0216% | ||
| 8/31/26 | Buy | Chief Executive Officer | -47,620 | 0.0216% | ||
| 8/31/26 | Buy | Director | 95,240 | 0.0432% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.32% | -8.43% | -24.00% | +8.57% | 62.64M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -1.54% | -1.96% | +23.89% | +77.43% | 59.26B | |
| +1.30% | -0.18% | +4.76% | +35.12% | 47.14B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 42.91B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 44.13B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 23.71B | |
| Average | -1.23% | -0.82% | +45.14% | +139.51% | 39.25B | |
| Weighted average by Cap. | -0.02% | -0.32% | +57.97% | +145.69% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 475K 422K 395K 360K 677K 45.77M 687K 4.78M 1.85M 23.31M 1.78M 1.75M 74.88M | 1.98M 1.76M 1.64M 1.5M 2.82M 190M 2.86M 19.88M 7.7M 97.01M 7.43M 7.27M 312M |
| Net income | -27.44M -24.38M -22.8M -20.77M -39.11M -2.64B -39.65M -276M -107M -1.35B -103M -101M -4.32B | -30.75M -27.31M -25.54M -23.28M -43.82M -2.96B -44.42M -309M -120M -1.51B -115M -113M -4.84B |
| Net Debt | -40.9M -36.33M -33.97M -30.96M -58.29M -3.94B -59.09M -411M -159M -2.01B -154M -150M -6.44B | -37.15M -33M -30.86M -28.12M -52.94M -3.58B -53.67M -373M -145M -1.82B -139M -136M -5.85B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | A$0.3800 | -7.32% | 657,846 |
| 26-10-01 | A$0.4100 | +1.86% | 352,163 |
| 26-09-30 | A$0.4025 | +0.63% | 123,484 |
| 26-09-29 | A$0.4000 | 0.00% | 33,606 |
| 26-09-28 | A$0.4000 | -3.61% | 492,023 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
